Advanced search×

RCL hydrolyzes 2'-deoxyribonucleoside 5'-monophosphate via formation of a reaction intermediate.

Biochemistry 50(21):4712-9 (2011) PMID 21510673

RCL is an enzyme that catalyzes the N-glycosidic bond cleavage of purine 2'-deoxyribonucleoside 5'-monophosphates. Recently, the structures of both free wild type and GMP-bound mutant complex have been determined by multidimensional NMR, revealing a doubly wound α/β protein existing in a symmetric homodimer. In this work, we investigated the catalytic mechanism by rational site-directed mutagenesis, steady-state and pre-steady-state kinetics, ITC binding analysis, methanolysis, and NMR study. First, we provide kinetic evidence in support of the structural studies that RCL functions in a dimeric form, with an apparent dissociation constant around 0.5 μM in the presence of substrate dGMP. Second, among the eight residues under investigation, the highly conserved Glu93 is absolutely critical and Tyr13 is also important likely contributing to the chemical step, whereas Ser117 from the neighboring subunit and Ser87 could be the key residues for the phosphate group recognition. Lastly, we demonstrate by methanolysis study that the catalytic reaction proceeds via the formation of a reaction intermediate, which is subsequently hydrolyzed by solvent nucleophile resulting in the formation of normal product deoxyribose monophosphate (dR5P) or methoylated-dR5P. In conclusion, the current study provides mechanistic insights into a new class of nucleotide hydrolase, which resembles nucleoside 2'-deoxyribosyltransferases structurally and functionally but also possesses clear distinction.

DOI: 10.1021/bi101742z
Version: za2963e q8za0 q8zbe q8zcd q8zde q8zea q8zfa q8zg1

Similar articles you may find interesting…

  1. Solution Structure of RCL, a Novel 2'-Deoxyribonucleoside 5'-Monophosphate N-glycosidase

    J Mol Biol 394(3):12 (2009) PMID 19720067

    We determined the solution structure by multidimensional NMR and provide a structural framework to elucidate its mechanism with computational simulation. RCL is a symmetric homodimer, with each monomer consisting of a five-stranded parallel beta-sheet sandwiched between five alpha-helices. Three of...
  2. Clinical investigation of neuraxially administered drugs: a regulatory perspective.

    Anesth Analg 109(2):299-300 (2009) PMID 19608794

  3. Therapeutic potential of panduratin A, LKB1-dependent AMP-activated protein kinase stimulator, with activation of PPARα/δ for the treatment ...

    Diabetes Metab 13(7):584-93 (2011) PMID 21320266

    Panduratin A, a LKB1-dependent AMPK stimulator, activated PPARα/δ and attenuated high-fat diet-induced obesity and dysregulation of lipid metabolism. Our findings suggest that panduratin A is a potent AMPK activator and demonstrate a novel molecular mechanism for the treatment of metabolic disorde...